Dar Bioscience Inc (DARE) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access DARE Annual Balance Sheets →
This balance sheet overview for Dar Bioscience Inc spans from Jun 30 2025 to Jun 30 2026, showing how the company's assets, liabilities, and equity have evolved across reporting periods.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent12.62
Cash & Short-term Investments12.00
Other Receivables, Net, Current0.00
Other Current Assets2.93
Prepaid Expense, Current AS0.84
Total Current Assets16.69
Equipment/Property/Plant Net1.42
Long-term investments0.30
Prepaid Expense AS2.78
Other Assets, Noncurrent1.19
Total Assets22.37
Liabilities
Accounts Payable, Current AC0.76
Accrued Liabilities, Current AC0.45
Long-term Debt, Current Maturities LO0.00
Other Liabilities, Current13.71
Deferred Revenue, Current DE2.00
Total Current Liabilities16.92
Total Long-term Debt0.00
Other liabilities, Noncurrent6.01
OperatingLeaseLiabilityNoncurrent0.42
Deferred Grant Funding Current18.15
Operating Lease Liability Current0.60
Contract With Customer Liability Noncurrent-
Total Liabilities22.93
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock194.48
Retained Earnings / Accumulated Deficit-194.67
Accumulated Other Comprehensive Income-0.37
Other Equity-0.37
Common Stockholder's Equity-0.96
Preferred Stockholder's Equity0.40
Total Stockholder's Equity-0.56
Liabilities & Stockholder's Equity22.37
4 historic quarters locked

Sign in to unlock the full Dar Bioscience Inc balance sheet history.

About Dare Bioscience Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001401914-26-000043

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.